cp 66713 has been researched along with propentofylline in 1 studies
| Studies (cp 66713) | Trials (cp 66713) | Recent Studies (post-2010) (cp 66713) | Studies (propentofylline) | Trials (propentofylline) | Recent Studies (post-2010) (propentofylline) |
|---|---|---|---|---|---|
| 22 | 0 | 4 | 255 | 15 | 54 |
| Protein | Taxonomy | cp 66713 (IC50) | propentofylline (IC50) |
|---|---|---|---|
| Acetylcholinesterase | Homo sapiens (human) | 6.4 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fredholm, BB; Hedqvist, P; Raud, J; Zhang, Y | 1 |
1 other study(ies) available for cp 66713 and propentofylline
| Article | Year |
|---|---|
Propentofylline inhibits polymorphonuclear leukocyte recruitment in vivo by a mechanism involving adenosine A2A receptors.
Topics: Animals; Anti-Ulcer Agents; Male; Mice; Neutrophils; Peritonitis; Purinergic P1 Receptor Antagonists; Pyrazines; Receptor, Adenosine A2A; Receptors, Purinergic P1; Xanthines; Zymosan | 1996 |